Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobazam in pediatric Dravet Syndrome
NCT02187809Phase 3Terminated
- Sponsor
- Lundbeck
- Start
- Mar 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Onfi in Dravet syndrome, sponsored by Lundbeck. Started Mar 2015; status: terminated.
02
Drugs
Onfi
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT02187809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02187809.